Bicara Therapeutics Inc (BCAX) insider trading
Every open-market stock purchase and sale by Bicara Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $40M over the last 12 months (1 buy).
- Insiders sold $9.6M over the last 12 months (33 sales).
- Last insider buy: Ra Capital Management L.p. (Insider), $35.2M, 7 months ago.
Last 12 months: insiders bought $40M (1 buy) and sold $9.6M (33 sales). Last close $20.00 on Jun 4, 2026.
Recent BCAX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | Christopher Bowden (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Jake Simson (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Michael Powell (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Scott M. Robertson (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Kiran Mazumdar-Shaw (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Kate Haviland (Director) | Bought (not open market) | — |
| May 21, 2026 | Ivan Hyep (CFO) | Sold | $188K |
| May 21, 2026 | Ivan Hyep (CFO) | Bought (not open market) | — |
| May 18, 2026 | Claire Mazumdar (CEO) | Sold | $240K |
| May 18, 2026 | Claire Mazumdar (CEO) | Sold | $60.6K |
| May 18, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
| May 15, 2026 | Ryan Cohlhepp (COO) | Sold | $162K |
| May 15, 2026 | Ryan Cohlhepp (COO) | Sold | $91.3K |
| May 15, 2026 | Ryan Cohlhepp (COO) | Bought (not open market) | — |
| May 8, 2026 | William Schelman (C-suite exec) | Bought (not open market) | — |
| Apr 27, 2026 | David Raben (C-suite exec) | Sold | $126K |
| Apr 27, 2026 | David Raben (C-suite exec) | Bought (not open market) | — |
| Apr 21, 2026 | Ivan Hyep (CFO) | Sold | $212K |
| Apr 21, 2026 | Ivan Hyep (CFO) | Bought (not open market) | — |
| Apr 20, 2026 | Claire Mazumdar (CEO) | Sold | $354K |
| Apr 20, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
| Apr 16, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
| Apr 16, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
| Apr 16, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
Who's trading BCAX
- Scott M. Robertson, Director: other filings, last Jun 9, 2026
- Ra Capital Management L.p., Insider: bought $40M (2 buys), last Jun 9, 2026
- Jake Simson, Director: other filings, last Jun 9, 2026
- Christopher Bowden, Director: other filings, last Jun 9, 2026
- Michael Powell, Director: other filings, last Jun 9, 2026
- Kiran Mazumdar-Shaw, Insider: other filings, last Jun 9, 2026
- Kate Haviland, Director: other filings, last Jun 9, 2026
- Ivan Hyep, CFO: sold $2.1M (13 sales), last May 21, 2026
- Claire Mazumdar, CEO: sold $3.5M (14 sales), last May 18, 2026
- Ryan Cohlhepp, COO: sold $2.8M (22 sales), last May 15, 2026
- William Schelman, C-suite exec: other filings, last May 8, 2026
- David Raben, C-suite exec: sold $1.1M (8 sales), last Apr 27, 2026
- Lara Meisner, C-suite exec: other filings, last Feb 2, 2026
Get free alerts when an insider at Bicara Therapeutics Inc files a new trade →